Skip to content
★ Sign in to follow
SK

Samer Kaba

Alimera Sciences Inc
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 11 Jan 2021 for Alimera Sciences INC.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Samer Kaba: trading record in brief

Samer Kaba discloses dealings in Alimera Sciences Inc to SEC (Form 4). In total, 12 filings cover trades dated from 13 September 2019 to 7 January 2021.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 11 January 2021 came the latest disclosure, a share grant in Alimera Sciences Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Samer Kaba

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    0SEC
    6,250 shares0Common StockSEC:0001474506-21-000028:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    0SEC
    4,683 shares0Common StockSEC:0001267602-20-000050:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    5,137 USD14SEC
    838 shares@ US$6.1334.3% of flowCommon StockSEC:0001267602-20-000043:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    4,718 USD14SEC
    838 shares@ US$5.6331.5% of flowCommon StockSEC:0001267602-20-000043:1
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    705 USD11SEC
    93 shares@ US$7.584.6% of flowCommon StockSEC:0001267602-20-000006:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    709 USD11SEC
    86 shares@ US$8.244.6% of flowCommon StockSEC:0001267602-19-000212:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    713 USD11SEC
    126 shares@ US$5.664.7% of flowCommon StockSEC:0001267602-19-000202:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    708 USD11SEC
    149 shares@ US$4.754.7% of flowCommon StockSEC:0001267602-19-000192:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    712 USD11SEC
    2,513 shares@ US$0.28344.6% of flowCommon StockSEC:0001267602-19-000165:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    712 USD11SEC
    1,779 shares@ US$0.404.7% of flowCommon StockSEC:0001267602-19-000147:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    712 USD11SEC
    1,249 shares@ US$0.574.7% of flowCommon StockSEC:0001267602-19-000140:0
  • ◆
    Chief Medical OfficerExecutivesAlimera Sciences Inc
    712 USD11SEC
    1,736 shares@ US$0.414.7% of flowCommon StockSEC:0001267602-19-000125:0

12 of 12 declarations